OlatorepatideStudy of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Sponsor:

Regeneron Pharmaceuticals

Code:

NCT07685808

Conditions

Overweight or Obesity

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Olatorepatide

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-02. This information was provided to ClinicalTrials.gov by Regeneron Pharmaceuticals on 2026-08-20.